
Baolingbao Biology Co.,Ltd.
SZSE:002286.SZ
7.46 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 2,401.755 | 2,523.914 | 2,712.745 | 2,764.977 | 2,054.578 | 1,805.17 | 1,730.012 | 1,592.996 | 1,377.424 | 1,196.282 | 910.71 | 900.769 | 978.028 | 950.773 | 720.615 | 525.4 | 536.555 | 414.326 | 257.343 |
Cost of Revenue
| 2,116.364 | 2,319.382 | 2,399.932 | 2,394.789 | 1,866.475 | 1,537.125 | 1,487.829 | 1,379.51 | 1,171.705 | 1,032.024 | 801.875 | 764.043 | 776.735 | 747.675 | 579.629 | 411.652 | 410.33 | 305.046 | 188.805 |
Gross Profit
| 285.391 | 204.532 | 312.813 | 370.188 | 188.104 | 268.045 | 242.183 | 213.486 | 205.719 | 164.258 | 108.836 | 136.727 | 201.293 | 203.098 | 140.987 | 113.747 | 126.225 | 109.279 | 68.538 |
Gross Profit Ratio
| 0.119 | 0.081 | 0.115 | 0.134 | 0.092 | 0.148 | 0.14 | 0.134 | 0.149 | 0.137 | 0.12 | 0.152 | 0.206 | 0.214 | 0.196 | 0.216 | 0.235 | 0.264 | 0.266 |
Reseach & Development Expenses
| 9.538 | 96.986 | 8.46 | 12.581 | 11.2 | 9.119 | 4.539 | 5.026 | 15.732 | 6.256 | 10.948 | 13.132 | 6.5 | 5.95 | 4.204 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 19.02 | 14.299 | 26.714 | 27.583 | 15.277 | 12.888 | 15.667 | 9.455 | 12.595 | 7.742 | 7.701 | 9.416 | 11.79 | 20.974 | 7.849 | 25.119 | 25.613 | 14.991 | 10.067 |
Selling & Marketing Expenses
| 15.847 | 17.737 | 36.794 | 33.909 | 31.801 | 114.204 | 111.856 | 102.27 | 96.429 | 89.11 | 62.548 | 57.613 | 67.714 | 73.414 | 43.504 | 21.144 | 19.29 | 16.858 | 9.352 |
SG&A
| 34.867 | 32.036 | 63.508 | 61.492 | 47.078 | 127.093 | 127.523 | 111.725 | 109.024 | 96.851 | 70.249 | 67.028 | 79.504 | 94.388 | 51.352 | 46.263 | 44.904 | 31.849 | 19.42 |
Other Expenses
| 87.019 | 11.502 | 73.226 | 63.892 | 57.175 | 56.302 | -2.41 | -0.806 | 8.96 | 10.82 | 14.559 | 18.324 | 8.604 | 4.692 | 9.036 | 10.571 | 4.075 | 2.782 | 0.024 |
Operating Expenses
| 131.424 | 140.524 | 145.194 | 137.966 | 115.453 | 192.513 | 170.674 | 156.873 | 168.314 | 138.656 | 111.516 | 110.836 | 119.243 | 130.865 | 79.496 | 48.782 | 48.624 | 33.781 | 20.283 |
Operating Income
| 153.967 | 64.008 | 160.23 | 235.93 | 60.736 | 85.331 | 54.073 | 57.895 | 49.7 | 36.754 | 13.939 | 30.688 | 71.112 | 61.259 | 41.549 | 35.748 | 49.012 | 49.455 | 31.319 |
Operating Income Ratio
| 0.064 | 0.025 | 0.059 | 0.085 | 0.03 | 0.047 | 0.031 | 0.036 | 0.036 | 0.031 | 0.015 | 0.034 | 0.073 | 0.064 | 0.058 | 0.068 | 0.091 | 0.119 | 0.122 |
Total Other Income Expenses Net
| -22.853 | 1.107 | -3.54 | 0.807 | -1.104 | -39.544 | -1.574 | -0.806 | 8.725 | 11.055 | 7.209 | 17.5 | 7.245 | -5.558 | -7.984 | -18.648 | -24.514 | 2.782 | 0.024 |
Income Before Tax
| 131.114 | 65.115 | 156.69 | 236.737 | 59.632 | 45.787 | 52.5 | 57.089 | 58.425 | 47.809 | 27.354 | 49.013 | 79.716 | 65.951 | 50.584 | 46.318 | 53.087 | 52.237 | 31.343 |
Income Before Tax Ratio
| 0.055 | 0.026 | 0.058 | 0.086 | 0.029 | 0.025 | 0.03 | 0.036 | 0.042 | 0.04 | 0.03 | 0.054 | 0.082 | 0.069 | 0.07 | 0.088 | 0.099 | 0.126 | 0.122 |
Income Tax Expense
| 19.954 | 11.146 | 23.521 | 35.158 | 9.77 | 10.862 | 9.858 | 7.992 | 9.222 | 6.863 | 3.431 | 7.083 | 12.394 | 10.234 | 7.78 | 7.045 | 8.31 | 18.94 | 11.336 |
Net Income
| 111.16 | 53.969 | 133.169 | 201.579 | 49.862 | 35.234 | 42.953 | 49.622 | 49.343 | 40.946 | 23.922 | 41.931 | 67.326 | 55.722 | 42.805 | 39.274 | 44.777 | 33.296 | 20.008 |
Net Income Ratio
| 0.046 | 0.021 | 0.049 | 0.073 | 0.024 | 0.02 | 0.025 | 0.031 | 0.036 | 0.034 | 0.026 | 0.047 | 0.069 | 0.059 | 0.059 | 0.075 | 0.083 | 0.08 | 0.078 |
EPS
| 0.3 | 0.15 | 0.36 | 0.55 | 0.14 | 0.095 | 0.12 | 0.13 | 0.13 | 0.11 | 0.06 | 0.12 | 0.26 | 0.21 | 0.16 | 0.23 | 0.22 | 0.19 | 0.2 |
EPS Diluted
| 0.3 | 0.15 | 0.36 | 0.55 | 0.14 | 0.095 | 0.12 | 0.13 | 0.13 | 0.11 | 0.06 | 0.12 | 0.26 | 0.21 | 0.16 | 0.23 | 0.22 | 0.19 | 0.2 |
EBITDA
| 263.698 | 218.499 | 292.35 | 367.329 | 174.677 | 174.521 | 166.149 | 136.55 | 135.306 | 105.351 | 74.566 | 107.995 | 135.248 | 117.22 | 97.808 | 105.465 | 106.153 | 91.398 | 58.993 |
EBITDA Ratio
| 0.11 | 0.087 | 0.108 | 0.133 | 0.085 | 0.097 | 0.096 | 0.086 | 0.098 | 0.088 | 0.082 | 0.12 | 0.138 | 0.123 | 0.136 | 0.201 | 0.198 | 0.221 | 0.229 |